MIRUM PHARMACEUTICALS, INC. (MIRM)
Clinical trial NCT05050136 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. completion date: 2027-07-01 → 2028-12-01 3. primary completion date: 2027-04-01 → 2027-01-01 4. enrollment: 260 → 333 participants 5. enrollment type: ESTIMATED → ACTUAL
📉 **NEGATIVE** • Medium confidence analysis (66%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (22%) **Content type:** Clinical